Louis Navellier, Navellier & Associates, shares his top tech plays for the next quarter. We should be rallying for most of October , says Navellier.
Jim Cramer revealed his top plays to snag if the market gets slammed by the Federal Reserve meeting next week.
Aside from the financial crisis, health care hasn't lagged the broader market this badly since Bill Clinton was president.
Jim Cramer on how home sales reaching highest levels since 2007 could be good news for the overall market.
Jim Cramer has confidence that one group of stocks is finally on the mend, as he shares his opinion on various caller stocks.
The FDA approves two transcatheter heart valves manufactured by Edwards Lifesciences, CNBC's Seema Mody reports.
Jon Najarian spots bullish options buying in Edwwards Lifesciences
"Power Lunch" hosts Melissa Lee and Brian Sullivan look at 5 stocks with analyst recommendations, including Coach & McDermott.
Jim Cramer highlights one group that was a clear winner of the first half of 2016.
Jim Cramer is a buyer of this medical stock, along with others, as he answers questions on caller favorite stocks.
Jim Cramer discovered one off-the-radar medical play where money managers are stuffing cash.
Shares of Johnson & Johnson dipped briefly Friday after an analyst took aim at the company's medical device business.
Some of the names on the move ahead of the open.
U.S. stocks closed lower Monday as pressure from a decline in oil prices mostly offset gains in health care stocks.
"Power Lunch" hosts Melissa Lee and Brian Sullivan look at 5 stocks with analyst recommendations, including upgrades for Edwards Lifesciences for its new heart valve procedure, and a triple downgrade for gun maker Smith & Wesson.
Jim Cramer explains why he is keeping an eye on shares of Edwards Lifesciences after the company announces the development of an engineered aortic heart value.
Michael Mussallem, Edwards Lifesciences CEO, talks about recent data on transcathether heart valves which show a minimally invasive procedure to replace the aortic heart valve is superior to open-heart surgery for patients with certain risks of complications.
Jim Cramer says the worldwide opportunity for this is greater than the stock.
Cramer studied the charts of thousands of stocks, and identified six groups in bull market mode that can roar even higher.
“Mad Money” host Jim Cramer’s giving investors his insight on how to play rotations.